by vesalius | Apr 21, 2021 | Press Releases
VANCOUVER, BC, April 21, 2021 /PRNewswire/ — Vesalius Cardiovascular Inc. (VCI), a Canadian MedTech company developing a Transfemoral Mitral Valve Repair (TMVr) solution, announced today the achievement of a new pre-clinical milestone with its...
Recent Comments